FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3012417755> ?p ?o ?g. }

• W3012417755 endingPage "127111" @default.
• W3012417755 startingPage "127111" @default.
• W3012417755 abstract "Abstract Cancer is a leading cause of human death worldwide. One of the greatest challenges in cancer therapy is the discovery and design of novel products with potential anti-tumor activities. In this study, a new protocol involves three-component condensation of the 3-amino-1,2,4-triazole as a 1,3-binucleophile, versatile aldehydes and N-methyl-1-(methylthio)-2-nitroethenamine as an enamine analogous in the presence of trichloroacetic acid as a Bronsted-Lowry acidic promoter leads to new functionalized N-alkyl-6-nitro-3,5-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine in moderate to good yields. The presence of five nitrogen heteroatoms in the product structure has gathered immense attention among chemists and biologists due to their biological values. Therefore, we evaluated the anti-tumor activity of our synthetic compounds on different cancer cells including human malignant melanoma cells (A375), prostate cancer cells (PC3 cells, LNCaP cells) and normal cells HDF (human dermal fibroblast). Notably, we found that compound 4b that contains a nitro group has the best anti-tumor activity on three different cancer cells. By using DAPI staining, we showed cancer cells death. Apoptosis induction was shown using quantitative real time PCR (qRT-PCR) by evaluating of Bax and Bcl2 mRNA levels. Finally, we demonstrated that 4b has epithelial-to-mesenchymal transition (EMT) inhibition effect on cancer cells (by induction of E-cadherin and reduction of vimentin mRNA expression levels as two potential EMT markers). So, 4b could be an anti-cancer promising drug. Although, in vivo experiments will be required to evaluate possible side effects." @default.
• W3012417755 created "2020-03-23" @default.
• W3012417755 creator A5034938701 @default.
• W3012417755 creator A5047757951 @default.
• W3012417755 creator A5070727235 @default.
• W3012417755 creator A5072935032 @default.
• W3012417755 date "2020-05-01" @default.
• W3012417755 modified "2023-10-03" @default.
• W3012417755 title "Synthesis and evaluation of anti-tumor activity of novel triazolo[1,5-a] pyrimidine on cancer cells by induction of cellular apoptosis and inhibition of epithelial-to-mesenchymal transition process" @default.
• W3012417755 cites W1655297579 @default.
• W3012417755 cites W1970868718 @default.
• W3012417755 cites W1979988883 @default.
• W3012417755 cites W1995716005 @default.
• W3012417755 cites W2005618507 @default.
• W3012417755 cites W2038055601 @default.
• W3012417755 cites W2056703832 @default.
• W3012417755 cites W2065942278 @default.
• W3012417755 cites W2069820798 @default.
• W3012417755 cites W2073525920 @default.
• W3012417755 cites W2076583198 @default.
• W3012417755 cites W2078711559 @default.
• W3012417755 cites W2083292257 @default.
• W3012417755 cites W2095012104 @default.
• W3012417755 cites W2098114049 @default.
• W3012417755 cites W2124092586 @default.
• W3012417755 cites W2162916643 @default.
• W3012417755 cites W2577017727 @default.
• W3012417755 cites W2900704553 @default.
• W3012417755 cites W2907842010 @default.
• W3012417755 cites W2949803734 @default.
• W3012417755 cites W2967338551 @default.
• W3012417755 cites W429570348 @default.
• W3012417755 doi "https://doi.org/10.1016/j.bmcl.2020.127111" @default.
• W3012417755 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32199733" @default.
• W3012417755 hasPublicationYear "2020" @default.
• W3012417755 type Work @default.
• W3012417755 sameAs 3012417755 @default.
• W3012417755 citedByCount "18" @default.
• W3012417755 countsByYear W30124177552020 @default.
• W3012417755 countsByYear W30124177552021 @default.
• W3012417755 countsByYear W30124177552022 @default.
• W3012417755 countsByYear W30124177552023 @default.
• W3012417755 crossrefType "journal-article" @default.
• W3012417755 hasAuthorship W3012417755A5034938701 @default.
• W3012417755 hasAuthorship W3012417755A5047757951 @default.
• W3012417755 hasAuthorship W3012417755A5070727235 @default.
• W3012417755 hasAuthorship W3012417755A5072935032 @default.
• W3012417755 hasConcept C104317684 @default.
• W3012417755 hasConcept C121608353 @default.
• W3012417755 hasConcept C126322002 @default.
• W3012417755 hasConcept C185592680 @default.
• W3012417755 hasConcept C190283241 @default.
• W3012417755 hasConcept C194232998 @default.
• W3012417755 hasConcept C198826908 @default.
• W3012417755 hasConcept C2779321679 @default.
• W3012417755 hasConcept C3020616263 @default.
• W3012417755 hasConcept C502942594 @default.
• W3012417755 hasConcept C55493867 @default.
• W3012417755 hasConcept C71924100 @default.
• W3012417755 hasConcept C76419328 @default.
• W3012417755 hasConcept C86803240 @default.
• W3012417755 hasConcept C95444343 @default.
• W3012417755 hasConcept C96232424 @default.
• W3012417755 hasConceptScore W3012417755C104317684 @default.
• W3012417755 hasConceptScore W3012417755C121608353 @default.
• W3012417755 hasConceptScore W3012417755C126322002 @default.
• W3012417755 hasConceptScore W3012417755C185592680 @default.
• W3012417755 hasConceptScore W3012417755C190283241 @default.
• W3012417755 hasConceptScore W3012417755C194232998 @default.
• W3012417755 hasConceptScore W3012417755C198826908 @default.
• W3012417755 hasConceptScore W3012417755C2779321679 @default.
• W3012417755 hasConceptScore W3012417755C3020616263 @default.
• W3012417755 hasConceptScore W3012417755C502942594 @default.
• W3012417755 hasConceptScore W3012417755C55493867 @default.
• W3012417755 hasConceptScore W3012417755C71924100 @default.
• W3012417755 hasConceptScore W3012417755C76419328 @default.
• W3012417755 hasConceptScore W3012417755C86803240 @default.
• W3012417755 hasConceptScore W3012417755C95444343 @default.
• W3012417755 hasConceptScore W3012417755C96232424 @default.
• W3012417755 hasFunder F4320322209 @default.
• W3012417755 hasIssue "10" @default.
• W3012417755 hasLocation W30124177551 @default.
• W3012417755 hasOpenAccess W3012417755 @default.
• W3012417755 hasPrimaryLocation W30124177551 @default.
• W3012417755 hasRelatedWork W2010684987 @default.
• W3012417755 hasRelatedWork W2154708791 @default.
• W3012417755 hasRelatedWork W2386605958 @default.
• W3012417755 hasRelatedWork W2501960686 @default.
• W3012417755 hasRelatedWork W2569030526 @default.
• W3012417755 hasRelatedWork W2898364729 @default.
• W3012417755 hasRelatedWork W3012168770 @default.
• W3012417755 hasRelatedWork W3017441656 @default.
• W3012417755 hasRelatedWork W3045584038 @default.
• W3012417755 hasRelatedWork W3156932517 @default.
• W3012417755 hasVolume "30" @default.
• W3012417755 isParatext "false" @default.
• W3012417755 isRetracted "false" @default.
• W3012417755 magId "3012417755" @default.

• next